14537131

Source:http://linkedlifedata.com/resource/pubmed/id/14537131

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0030705, umls-concept:C0032743, umls-concept:C0449468, umls-concept:C0684249, umls-concept:C1521840, umls-concept:C1522449, umls-concept:C1704788
pubmed:issue	3
pubmed:dateCreated	2003-10-10
pubmed:abstractText	To discuss the potential contribution of 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography (FDG-PET) in radiotherapy planning for non-small-cell lung cancer (NSCLC) considering new concepts on target volume definition.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/101125610
pubmed:status	PubMed-not-MEDLINE
pubmed:month	May
pubmed:issn	1536-1632
pubmed:author	pubmed-author:BaumannMichaelM, pubmed-author:HellwigDirkD, pubmed-author:KirschCarl MartinCM, pubmed-author:LichtNorbertN, pubmed-author:NestleUrsulaU, pubmed-author:RübeChristianC, pubmed-author:SchmidtSylviaS, pubmed-author:UkenaDieterD, pubmed-author:WalterKarinK
pubmed:issnType	Print
pubmed:volume	4
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	257-63
pubmed:year	2002
pubmed:articleTitle	2-Deoxy-2-[18F]fluoro-D-glucose positron emission tomography in target volume definition for radiotherapy of patients with non-small-cell lung cancer.
pubmed:affiliation	Department of Nuclear Medicine, Saarland University Medical Center, Homburg/Saar, Germany.
pubmed:publicationType	Journal Article